Bharat Biotech's intranasal COVID-19 vaccine to enter phase 1 trials next month

Replying to a query on the probable pricing of Covaxin, he said Indian vaccines will be much cheaper when compared to other countries.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news